When we further screened whether these signaling pathways are perturbed in GDF15-knockdowned gastric cancer cells, we found that the activation of AKT, ERK, p38, and NF-κB was not different between shCtrl and GDF15-knockdown gastric cancer cells (Figure S2A). The gene discussed is AKT1; the disease is gastric cancer.